Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Tables)

v3.24.3
Stockholders’ Equity (Tables)
9 Months Ended
Sep. 30, 2024
Equity [Abstract]  
Schedule of Stock Options Activity
The following table summarizes stock option activity during the nine months ended September 30, 2024, (in thousands, except per share data).
Number of Shares Weighted Average Exercise Price  Weighted Average Remaining Contractual Life
(in years)
Total Intrinsic Value
Outstanding as of January 1, 2024 2,951 $ 7.30  4.8 $ 693 
Granted 1,840 6.01  7.0 — 
Forfeited (872) 7.53  —  — 
Outstanding as of September 30, 2024 3,919 $ 6.64  5.2 23 
Options vested and exercisable 2,031 $ 6.55  4.3 23 
Schedule of Weighted Average Assumptions Used in Determining Fair Value of Options
The following table summarizes weighted average assumptions used in determining the fair value of the stock options at the date of grant during the nine months ended September 30, 2024 and 2023:
For the nine months ended
September 30, 2024 September 30, 2023
Exercise price $ 6.01  $ 8.65 
Expected term (years) 4.5 4.7
Expected stock price volatility 79.6  % 80.0  %
Risk-free rate of interest 4.2  % 3.7  %
Expected dividend yield (per share) % %
Schedule of Warrant Activity
The following table summarizes warrant activity during the nine months ended September 30, 2024 (in thousands, except per share data):
Number of Shares Weighted Average Exercise
Price
Weighted Average
Remaining Contractual Life
 (in years)
Outstanding as of January 1, 2024 831 $ 11.16  1.9
Forfeited (455) 12.83
Outstanding as of September 30, 2024 376 $ 9.13  3.4
Warrants vested and exercisable 376 $ 9.13  3.4